Long-term treatment with interferon alfa for myeloproliferative neoplasms

被引：9
|
作者：
Kiladjian, Jean-Jacques [1 ,2 ]
机构：
[1] Univ Paris Diderot, Hop St Louis, AP HP, INSERM CIC 1427, Paris, France
[2] Hop St Louis, Ctr Invest Clin, F-75010 Paris, France
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 04期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; HYDROXYUREA; ANAGRELIDE; TRIAL;
D O I：
10.1016/S2352-3026(17)30039-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E150 / E151
页数：2
相关论文
共 50 条
  • [21] LONG-TERM TREATMENT WITH DIFFERENT REGIMENS OF RECOMBINANT INTERFERON-ALFA IN CHRONIC HEPATITIS-C
    PODDA, M
    BATTEZZATI, PM
    ZUIN, M
    BRUNO, S
    GALLOTTI, P
    BORZIO, M
    BORZIO, F
    FORNARI, F
    LANZINI, A
    SALMI, A
    RUSSO, A
    HEPATOLOGY, 1995, 22 (04) : 55 - 55
  • [22] ADVERSE REACTIONS IN LONG-TERM INTERFERON TREATMENT
    LEVENS, WJ
    FISCHER, N
    INGEHAG, W
    RUBBEN, H
    SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (03): : 204 - 206
  • [23] Long-term risks of cardiovascular-specific mortality among myeloproliferative neoplasms patients
    Tang, Meiling
    Chen, Ying
    Zhou, Yanying
    Zhuang, Xinran
    Fu, Yuxin
    Chen, Jinzheng
    Wei, Rongfang
    Chen, Yan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [24] Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
    Hoekstra, J.
    Bresser, E. L.
    Smalberg, J. H.
    Spaander, M. C. W.
    Leebeek, F. W. G.
    Janssen, H. L. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2208 - 2214
  • [25] LONG-TERM RESULTS IN THE TREATMENT OF EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT ALPHA-2C INTERFERON
    GISSLINGER, H
    LINKESCH, W
    CHOTT, A
    SINZINGER, H
    LUDWIG, H
    BLUT, 1986, 53 (03): : 128 - 128
  • [26] Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
    Yoon, Seug Yun
    Kim, Sung-Yong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (06): : 810 - 817
  • [27] Long-term follow-up after alfa-interferon treatment for chronic hepatitis D.
    Farci, P
    Chessa, L
    Peddis, G
    Orgiana, G
    Scioscia, R
    Degioannis, D
    Lai, ME
    Roskams, T
    Desmet, V
    Balestrieri, A
    HEPATOLOGY, 1999, 30 (04) : 343A - 343A
  • [28] Painless thyroiditis occurring during long-term treatment with interferon alfa in a patient with chronic active hepatitis C
    Uchida, K
    Matsui, A
    Nakano, S
    Kigoshi, T
    Morimoto, S
    SOUTHERN MEDICAL JOURNAL, 1996, 89 (01) : 81 - 83
  • [29] ELUCIDATING THE MECHANISM OF ACTION OF INTERFERON- A THERAPY IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Jayarajan, Jeyan
    Knoch, Julia
    Ball, Melanie
    Buechler, Marleen
    Milsom, Michael
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S65 - S65
  • [30] Myeloproliferative neoplasms and splanchnic vein thrombosis: Results of a long-term UK prospective cohort study
    Hargreaves, Rupen
    Danaee, Anicee
    Patch, David
    Karkhanis, Salil
    Kaddam, Israa
    Kim, Jin Un
    Hussein, Hayder
    Chen, Frederick
    Yu, Dominic
    Tripathi, Dhiraj
    Sekhar, Mallika
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 164 - 165
12345